Skip to main content
Clinical Trials/JPRN-jRCTs051180123
JPRN-jRCTs051180123
Active, Not Recruiting
N/A

Clinical study on the efficacy of flutamide for androgen dependent dilated cardiomyopathy - FLUADE DCM trial

Onoue Kenji0 sites2 target enrollmentMarch 13, 2019

Overview

Phase
N/A
Intervention
Not specified
Conditions
Not specified
Sponsor
Onoue Kenji
Enrollment
2
Status
Active, Not Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
March 13, 2019
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
Female

Investigators

Sponsor
Onoue Kenji

Eligibility Criteria

Inclusion Criteria

  • 1\. Patients with androgen dependent familial dilated cardiomyopathy.
  • 2\. Patients who are sufficiently understood that standard treatments indicate no adequate therapeutic efficacy.
  • 3\. Patients who are sufficiently understood that the efficacy and safety of flutamide was not yet fully secured.
  • 4\. Patients who are able to provide signed informed consent.

Exclusion Criteria

  • 1\. Patients with a history of hypersensitivity to flutamide.
  • 2\. Patients with hepatic impairment.
  • 3\. Patients who are not able to provide signed informed consent.

Outcomes

Primary Outcomes

Not specified

Similar Trials